On the one hand, ILC3s are thought to promote the proliferation, invasion and migration of PC cells through the IL-22/IL-22R-AKT signaling pathways, indicating a latent, promising and brand-new intervention target for PC treatment [127]. The gene discussed is AKT1; the disease is pachyonychia congenita.